Low ERG and BAALC expression identifies a new subgroup of adult acute T-lymphoblastic leukemia with a highly favorable outcome.
about
Diagnosis and subclassification of acute lymphoblastic leukemiaThe molecular profile of adult T-cell acute lymphoblastic leukemia: mutations in RUNX1 and DNMT3A are associated with poor prognosis in T-ALL.Immature MEF2C-dysregulated T-cell leukemia patients have an early T-cell precursor acute lymphoblastic leukemia gene signature and typically have non-rearranged T-cell receptors.Gene expression classifiers for relapse-free survival and minimal residual disease improve risk classification and outcome prediction in pediatric B-precursor acute lymphoblastic leukemia.Prognostic implications of mutations and expression of the Wilms tumor 1 (WT1) gene in adult acute T-lymphoblastic leukemia.Quantification of miRNA-mRNA interactionsIntronic miR-3151 within BAALC drives leukemogenesis by deregulating the TP53 pathway.Low expression of T-cell transcription factor BCL11b predicts inferior survival in adult standard risk T-cell acute lymphoblastic leukemia patientsFLT3 mutations in early T-cell precursor ALL characterize a stem cell like leukemia and imply the clinical use of tyrosine kinase inhibitorsT-cell acute lymphoblastic leukemia in adults: clinical features, immunophenotype, cytogenetics, and outcome from the large randomized prospective trial (UKALL XII/ECOG 2993)Molecular diagnostics in acute leukemias.Prognostic relevance of RUNX1 mutations in T-cell acute lymphoblastic leukemia.Clinical and molecular characterization of early T-cell precursor leukemia: a high-risk subgroup in adult T-ALL with a high frequency of FLT3 mutationsHeritable polymorphism predisposes to high BAALC expression in acute myeloid leukemiaPrognostic implications of NOTCH1 and FBXW7 mutations in adult acute T-lymphoblastic leukemia.ETS-related gene is a novel prognostic factor in childhood acute lymphoblastic leukemia.Adult acute lymphoblastic leukemia: concepts and strategies.A previously unrecognized promoter of LMO2 forms part of a transcriptional regulatory circuit mediating LMO2 expression in a subset of T-acute lymphoblastic leukaemia patients.BAALC-associated gene expression profiles define IGFBP7 as a novel molecular marker in acute leukemia.Prognostic significance of expression levels of stem cell regulators MSI2 and NUMB in acute myeloid leukemia.Immunophenotypic analysis of T-acute lymphoblastic leukemia. A CD5-based ETP-ALL perspective of non-ETP T-ALL.Erg and AP-1 as determinants of glucocorticoid response in acute lymphoblastic leukemia.Identification of novel neuroendocrine-specific tumour genes.Prognostic value of brain and acute leukemia cytoplasmic gene expression in egyptian children with acute myeloid leukemia.Poor Response to Standard Chemotherapy in Early T-precursor (ETP)-ALL: A Subtype of T-ALL Associated with Unfavourable Outcome: A Brief ReportmRNA overexpression of BAALC: A novel prognostic factor for pediatric acute lymphoblastic leukemia.Up-regulation of BAALC gene may be an important alteration in AML-M2 patients with t(8;21) translocation.Mutations of NOTCH1, FBXW7, and prognosis in T-lineage acute lymphoblastic leukemia.Core binding factor acute myeloid leukemia: the impact of age, leukocyte count, molecular findings, and minimal residual disease.Current challenges and opportunities in treating adult patients with Philadelphia-negative acute lymphoblastic leukaemia.Role of BAALC Gene in Prognosis of Acute Lymphoblastic Leukemia in Egyptian Children.Acute leukemias of ambiguous lineage in adults: molecular and clinical characterization.Functional role of BAALC in leukemogenesis.Prognostic implications and molecular associations of NADH dehydrogenase subunit 4 (ND4) mutations in acute myeloid leukemia.
P2860
Q26824387-9E2AB259-E5EB-4E99-8925-7F6C995B6DB6Q27852046-A73805CC-2C04-4FB6-B59F-3982A4057C29Q33558120-B6B6CCE2-AA9C-4105-B1D9-74519ACAEE43Q33680280-90B9D496-DE71-47C2-BBB5-8D370BFE5BBDQ33886181-92AA9ABA-A223-4F7F-9350-66FFE6B85638Q34163271-1E13CBC0-C047-44FD-BF0D-97A709B4E8BFQ34193684-472B45C6-71FB-4C72-8FDE-00317E821595Q34469099-077BE7CC-E533-4627-8465-8E65A585F6E9Q34566158-CB67C2C1-40C6-4397-A11A-402F81324022Q34612782-9448A0B5-B04C-431F-B158-E55E7630CBF5Q35007333-26DC6738-79B6-4FDF-A891-2F9D9174BC9AQ35596960-C01D3BEF-54F9-4B56-B667-BD797522104BQ35723764-FCF2E659-6846-41DF-A9C2-8E4266649508Q35922032-9518A7F8-9605-4384-A23A-2E889A02CF1DQ37369925-FC57C559-FFE8-4F48-997D-17BAE3AF02D0Q37594153-2D562EC6-F8E7-429C-94C3-A2E0A1E8E245Q37681450-DC444BA5-B2BF-4557-A969-ACE0F17F2852Q38341980-FA4C82D7-58F0-487C-9AAD-5347EBFAD20CQ38343448-F4353054-178D-49BE-94E4-545051D71D44Q38459847-A22F92A6-A384-4527-97A1-68AFDA5E093DQ39296606-00367F5B-65D1-4332-8990-24F671D50954Q39301443-942D7E65-62B2-4DBF-9D2A-E6DF94D9FAB9Q39933886-2A902C60-9CE3-47A4-946D-F569310D6C47Q40219910-8B8A8ACC-72DD-46FE-9DA3-DABF48E99025Q42019868-B67766BE-9226-4515-8D66-5B029CF8443BQ42177488-087121EF-714E-47D4-9527-871C1C51AEE4Q42386142-DBA16A1C-C005-481D-A992-914D15900791Q42574005-C9DE3302-2370-49C2-9EEC-345FAD239274Q45800079-9A5D1C8D-B61D-4700-8F22-45F00021FBDAQ47706549-F3F5E193-0264-420B-8B47-910A9965F8FFQ49338336-1BCDBAA6-9E08-40E0-8AA5-E6C410D17008Q52884875-DBF53933-95E8-45B0-9FD7-AACCF0502B0CQ53409067-A7E8B555-F626-453C-A8E0-F46AE2D63EA0Q54355087-81E93015-F724-4C8C-8B06-86CF4E58A081
P2860
Low ERG and BAALC expression identifies a new subgroup of adult acute T-lymphoblastic leukemia with a highly favorable outcome.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
Low ERG and BAALC expression i ...... th a highly favorable outcome.
@en
Low ERG and BAALC expression i ...... th a highly favorable outcome.
@nl
type
label
Low ERG and BAALC expression i ...... th a highly favorable outcome.
@en
Low ERG and BAALC expression i ...... th a highly favorable outcome.
@nl
prefLabel
Low ERG and BAALC expression i ...... th a highly favorable outcome.
@en
Low ERG and BAALC expression i ...... th a highly favorable outcome.
@nl
P2093
P356
P1476
Low ERG and BAALC expression i ...... th a highly favorable outcome.
@en
P2093
Claudia D Baldus
Dieter Hoelzer
Eckhard Thiel
Nicola Gökbuget
Peter Martus
Stefan Schwartz
Wolf K Hofmann
P304
P356
10.1200/JCO.2007.11.5253
P407
P577
2007-07-23T00:00:00Z